Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Citrin

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|June 8, 1974
Quantitative bone scanning: a method for assessing response of bone metastases to treatmentD L Citrin, R G Bessent, J B Tuohy, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancerN B Haas, J Manola, G Hudes, et al.
Cancer|November 1, 1978
o,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacementT F Hogan, D L Citrin, B M Johnson, et al.
The British Journal of Surgery|March 1, 1975
The application of the 99Tcm phosphate bone scan to the study of breast cancerD L Citrin, R G Bessent, W R Greig, et al.
Clinical Oncology|March 1, 1980
Serial scintiscanning in breast cancer: the indications and prognostic valueC M Furnival, L H Blumgart, D L Citrin, et al.
The British Journal of Radiology|September 1, 1980
Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone valuesI Fogelman, I D Hay, D L Citrin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1979
A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communicationI Fogelman, D L Citrin, J H McKillop, et al.
European Journal of Nuclear Medicine|August 1, 1979
Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic indexI Fogelman, D L Citrin, J G Turner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1978
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone diseaseI Fogelman, R G Bessent, J G Turner, et al.
Cancer|August 1, 1985
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancerD L Citrin, M S Kies, C B Wallemark, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|June 8, 1974
Quantitative bone scanning: a method for assessing response of bone metastases to treatmentD L Citrin, R G Bessent, J B Tuohy, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancerN B Haas, J Manola, G Hudes, et al.
Cancer|November 1, 1978
o,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacementT F Hogan, D L Citrin, B M Johnson, et al.
The British Journal of Surgery|March 1, 1975
The application of the 99Tcm phosphate bone scan to the study of breast cancerD L Citrin, R G Bessent, W R Greig, et al.
Clinical Oncology|March 1, 1980
Serial scintiscanning in breast cancer: the indications and prognostic valueC M Furnival, L H Blumgart, D L Citrin, et al.
The British Journal of Radiology|September 1, 1980
Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone valuesI Fogelman, I D Hay, D L Citrin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1979
A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communicationI Fogelman, D L Citrin, J H McKillop, et al.
European Journal of Nuclear Medicine|August 1, 1979
Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic indexI Fogelman, D L Citrin, J G Turner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1978
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone diseaseI Fogelman, R G Bessent, J G Turner, et al.
Cancer|August 1, 1985
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancerD L Citrin, M S Kies, C B Wallemark, et al.
Pageof 6